Alejandrino, Crispulo F.

HRN: 20-80-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/06/2026
05/12/2026
IV
600mg
Q6
Nonhealing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: